Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 9, 2017
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2016.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not contain specific details regarding material changes versus prior periods. It only confirms that results for the three months and year ended December 31, 2016, were announced.
Guidance, Outlook, and Risks
Management Commentary: The company announced a conference call to be held at 4:30 PM EST on March 9, 2017, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2016.
- Verify the details of the conference call held on March 9, 2017, for management's commentary on year-over-year performance.
- Confirm whether the press release includes updated forward-looking guidance or outlook for 2017.
- Check for any specific risk factors or contingencies disclosed in the full press release text not summarized in this 8-K cover.